Post-COVID-19 Spondylodiscitis: A Case Study and Review of the Literature

Medicina (Kaunas). 2023 Mar 20;59(3):616. doi: 10.3390/medicina59030616.

Abstract

COVID-19 is currently a major health problem, leading to respiratory, cardiovascular and neurological complications, with additional morbidity and mortality. Spinal infections are rare, representing around 1% of all bone infections and comprising less than 2 per 10,000 of all hospitalizations in tertiary care centers. Spondylodiscitis is a complex disease, with challenging diagnosis and management. We report the case of a 45-year-old man, non-smoker hospitalized for severe COVID-19 disease with respiratory failure. Post-COVID-19, in the 8th week after discharge, he was diagnosed by magnetic resonance imaging with spondylodiscitis, but etiology was not confirmed by microbiological investigations. Antibiotics were used, considering the identification of MRSA from cultures of pleural fluid and nasal swab, but surgical intervention was not provided. Clinic, biologic and imagistic were improved, but rehabilitation and long term follow up are necessary. We concluded that spondylodiscitis with spinal abscess is a rare but severe complication post-COVID-19 disease, due to dysbalanced immune response related to the respiratory viral infection, endothelial lesions, hypercoagulation and bacterial superinfection.

Keywords: COVID-19; MRSA; SARS-COV-2; spinal epidural abscess; spondylodiscitis.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Abscess / complications
  • Anti-Bacterial Agents
  • COVID-19* / complications
  • Discitis* / diagnosis
  • Discitis* / microbiology
  • Humans
  • Male
  • Middle Aged
  • Nervous System Diseases*

Substances

  • Anti-Bacterial Agents

Grants and funding

This research received no external funding.